Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

Even When Nearby, Public AEDs Get Little Use in OHCA

News Conference News ACC 2024

Even When Nearby, Public AEDs Get Little Use in OHCA

March 28, 2024

ESC/EACTS Task Force Recommends Downgrading PCI in Left Main CAD

News Conference News ESC 2023

ESC/EACTS Task Force Recommends Downgrading PCI in Left Main CAD

Michael O'Riordan

September 05, 2023

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

News Daily News

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

December 16, 2022

Cardiogenic Shock Teams May Lower Mortality in Cardiac ICUs

News Daily News

Cardiogenic Shock Teams May Lower Mortality in Cardiac ICUs

September 21, 2021

Statins Not Linked to Dementia or Memory Changes: ASPREE

News Daily News

Statins Not Linked to Dementia or Memory Changes: ASPREE

Michael O'Riordan

June 21, 2021

COVID-19: TCTMD’s Daily Dispatch for November

News

COVID-19: TCTMD’s Daily Dispatch for November

November 01, 2020

COVID-19: TCTMD’s Daily Dispatch for July

News Daily News

COVID-19: TCTMD’s Daily Dispatch for July

July 31, 2020

FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat

News Daily News

FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat

February 22, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

January 11, 2019

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

News Daily News

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

June 19, 2018

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

News Conference News ACC 2018

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

March 14, 2018

ACC 2018, Day Three: Gout, Hypertension, and Diabetes Dominate Opening Late Breaker

News Conference News ACC 2018

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

March 12, 2018

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout and Cardiovascular Disease (The CARES Trial)

Presentation ACC 2018

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout and Cardiovascular Disease (The CARES Trial)

Presenter: William B. White

March 11, 2018

News Daily News

Early Invasive Approach After Cardiac Arrest Gains Support

October 28, 2015

News Opinion Fellow Talk

5 Tips for Successfully Matching With an Interventional Cardiology Fellowship Program

Sarah Elsayed, MD

July 13, 2015

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

May 22, 2012

News Daily News

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

November 02, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.